Alopecia

22 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Alopecia Areata 8

Treatments and conditions

Alopecia
Treatment and conditionWhere it standsTrials
ABS-201 SC Multiple Doses + Placebo SC Injection for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
AD-303A for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Adalimumab for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baricitinib for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baricitinib for alopecia areataTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Botulinum toxin type a for alopeciaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deuruxolitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for alopeciaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mesenchymal Stem Cells for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Minoxidil for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Placebo for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 100 mg + Ritlecitinib 50 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 50 mg + Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo IV + SAD IV Dose 1 - 150mg ABS201 IV Single Dose for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
PP405 0.05% Topical Gel for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Ustekinumab for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VDPHL01 for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
VDPHL01 BID for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VDPHL01 QD for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.